Broad and potent HIV-1 neutralization in fusion peptide-primed SHIV-boosted macaques.
Wang, H.To be published.
Experimental Data Snapshot
wwPDB Validation   3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
BG505 DS-SOSIP Surface protein gp120 | 481 | Human immunodeficiency virus 1 | Mutation(s): 6  Gene Names: env | ||
UniProt | |||||
Find proteins for Q2N0S6 (Human immunodeficiency virus 1) Explore Q2N0S6  Go to UniProtKB:  Q2N0S6 | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | Q2N0S6 | ||||
Glycosylation | |||||
Glycosylation Sites: 15 | |||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
BG505 DS-SOSIP Transmembrane protein gp41 | 153 | Human immunodeficiency virus 1 | Mutation(s): 2  Gene Names: env | ||
UniProt | |||||
Find proteins for Q2N0S5 (Human immunodeficiency virus 1) Explore Q2N0S5  Go to UniProtKB:  Q2N0S5 | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | Q2N0S5 | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 3 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
DJ85-c.01 FAB HEAVY CHAIN | G, I [auth K] | 237 | Homo sapiens | Mutation(s): 0  | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 4 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
DJ85-c.01 FAB LIGHT CHAIN | H, J [auth L] | 214 | Homo sapiens | Mutation(s): 0  | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 5 | |||||
---|---|---|---|---|---|
Molecule | Chains | Length | 2D Diagram | Glycosylation | 3D Interactions |
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | BA [auth Z], CA [auth b], DA [auth d], EA [auth e], FA [auth f], BA [auth Z], CA [auth b], DA [auth d], EA [auth e], FA [auth f], GA [auth g], IA [auth i], JA [auth j], K [auth a], L [auth I], LA [auth l], M [auth J], MA [auth m], NA [auth n], O [auth N], P [auth O], R [auth Q], S [auth R], T [auth S], U [auth c], V [auth T], W [auth U], Y [auth W], Z [auth X] | 2 | N-Glycosylation | ||
Glycosylation Resources | |||||
GlyTouCan:  G42666HT GlyCosmos:  G42666HT GlyGen:  G42666HT |
Entity ID: 6 | |||||
---|---|---|---|---|---|
Molecule | Chains | Length | 2D Diagram | Glycosylation | 3D Interactions |
beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | HA [auth h], N [auth M], X [auth V] | 3 | N-Glycosylation | ||
Glycosylation Resources | |||||
GlyTouCan:  G15407YE GlyCosmos:  G15407YE GlyGen:  G15407YE |
Entity ID: 7 | |||||
---|---|---|---|---|---|
Molecule | Chains | Length | 2D Diagram | Glycosylation | 3D Interactions |
alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | AA [auth Y], KA [auth k], Q [auth P] | 5 | N-Glycosylation | ||
Glycosylation Resources | |||||
GlyTouCan:  G42227JK GlyCosmos:  G42227JK GlyGen:  G42227JK |
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
NAG Query on NAG | AB [auth E] BB [auth E] CB [auth E] OA [auth A] PA [auth A] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N |
Task | Software Package | Version |
---|---|---|
MODEL REFINEMENT | PHENIX | 1.20 |
RECONSTRUCTION | cryoSPARC | 3.3 |
Funding Organization | Location | Grant Number |
---|---|---|
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) | United States | -- |